Andrew Robbins Salary and Compensation - Cogent Biosciences, Inc. CEO Pay 2024

In fiscal year 2024, Andrew Robbins, Chief Executive Officer of Cogent Biosciences, Inc. (COGT), received total compensation of $4.9 million.

Andrew Robbins's compensation breakdown includes: base salary of $692K, option awards of $3.7 million, non-equity incentive compensation of $477K, and other compensation of $14K.

Compared to fiscal year 2023, Andrew Robbins's total compensation decreased 38% from $7.9 million to $4.9 million.

Cogent Biosciences, Inc. (COGT) Executive Pay 2024

Cogent Biosciences, Inc.'s top 5 named executive officers received combined total compensation of $14.3 million in fiscal year 2024.

The named executive officers disclosed in Cogent Biosciences, Inc.'s 2024 proxy statement are:Andrew Robbins (Chief Executive Officer) with total compensation of $4.9 million, Cole Pinnow (Chief Commercial Officer) with total compensation of $4.0 million, Jessica Sachs (Chief Medical Officer) with total compensation of $1.8 million, John Robinson (Chief Scientific Officer) with total compensation of $1.8 million, and John Green (Chief Financial Officer) with total compensation of $1.7 million.